Скачать или смотреть UM - Bsc. Business Engineering - BENC2003 - Commercializing Technology & Science - Case-based video

🔬 Carmat & the Artificial Heart Revolution: A Business Case Study 🫀

In this video, we explore the fascinating journey of Carmat, a pioneering French medtech company behind Aeson®, the world’s most advanced total artificial heart (TAH). Through a business and innovation lens, we analyze how Carmat identified a critical unmet clinical need—end-stage heart failure—and transformed a visionary medical concept into a commercial product.

💡 What you'll learn:

The origin and innovation behind Aeson®, led by renowned surgeon Professor Carpentier
Key technological breakthroughs and patented features
Challenges faced in clinical trials and regulatory approvals
Strategic funding, reimbursement models, and market positioning
Carmat’s competitive edge in the TAH landscape
Future roadmap: toward a fully implantable, permanent artificial heart

This is a student project created for academic purposes, combining business strategy, healthcare innovation, and real-world commercialization challenges.
🎥 Includes:
✔️ Clinical & engineering footage of Aeson®
✔️ Stock visuals for illustrative storytelling
✔️ Real insights into medtech go-to-market strategies

📌 Disclaimer: This content is intended for educational use only. See the disclaimer at the bottom for details.
If you enjoyed the video, don’t forget to like, comment, and subscribe for more content on innovation, medtech, and startup strategy!

#Carmat #Aeson #ArtificialHeart #Medtech #HealthcareInnovation #StudentProject #Cardiology #startupstrategy

Disclaimer
This video is created for educational and informational purposes as part of a student project analyzing the commercialization of Carmat. It does not provide medical, financial, or investment advice. All content, including research, opinions, and analysis, is based on publicly available information and does not represent official statements from Carmat or any affiliated organizations.

Some footage used in this video may include royalty-free, Creative Commons, or commercially licensed materials. No copyright infringement is intended. If you are the copyright holder of any materials used and have concerns about their inclusion, please contact me through the email listed in the "About" section of this channel, and I will address the issue promptly.

This video falls under fair use guidelines for educational and commentary purposes.